BIA
VRTX icon

Bell Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bell Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.6K Sell
129
-3
-2% -$1.4K 0.01% 231
2025
Q4 		$59.8K Buy
132
+27
+26% +$11.6K 0.01% 234
2025
Q3 		$41.1K Sell
105
-10
-9% -$4.18K 0.01% 268
2025
Q2 		$51.2K Hold
115
– – 0.01% 243
2025
Q1 		$55.8K Sell
115
-2
-2% -$932 0.01% 211
2024
Q4 		$47.1K Sell
117
-3
-3% -$1.39K 0.01% 227
2024
Q3 		$55.8K Hold
120
– – 0.01% 215
2024
Q2 		$56.2K Buy
120
+1
+0.8% +$434 0.01% 201
2024
Q1 		$49.7K Buy
119
+9
+8% +$3.81K 0.01% 207
2023
Q4 		$44.8K Buy
110
+3
+3% +$1.11K 0.01% 210
2023
Q3 		$37.2K Buy
107
+4
+4% +$1.4K 0.01% 209
2023
Q2 		$36.2K Buy
103
+10
+11% +$3.37K 0.01% 206
2023
Q1 		$29.3K Sell
93
-10
-10% -$3K 0.01% 235
2022
Q4 		$29.7K Buy
103
+11
+12% +$3.35K 0.01% 235
2022
Q3 		$27K Sell
92
-4
-4% -$1.15K 0.01% 217
2022
Q2 		$27K Buy
+96
New +$25.7K 0.01% 219
2021
Q4 		$18K Buy
80
+70
+700% +$13.6K ﹤0.01% 344
2021
Q3 		$2K Buy
+10
New +$1.95K ﹤0.01% 1180

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bell Investment Advisors's VRTX Position: Q1 2026 in Review

Bell Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.3% in Q1 2026, selling an estimated $1.4K and leaving 129 shares worth $57.6K. The position accounts for 0.01% of the portfolio, ranked #231.

Bell Investment Advisors first reported a position in VRTX in Q3 2021 and has held it in 18 quarters since. The position peaked at $59.8K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bell Investment Advisors held 129 shares of Vertex Pharmaceuticals worth $57.6K as of Q1 2026.
  • Bell Investment Advisors sold 3 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.4K.
  • Vertex Pharmaceuticals made up 0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #231 holding.
  • Bell Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Bell Investment Advisors's Vertex Pharmaceuticals position peaked at $59.8K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.